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Abstract
The frequent usage of antibiotics in livestock has led to the spread of resistant bacteria within animals and their
products, with a global warning in public health and veterinarians to monitor such resistances. This study aimed to
determine antibiotic resistance patterns and genes in pig farms from Spain during the last twenty years.
Susceptibility to six antibiotics commonly used in pig production was tested by qualitative (disk diffusion) and
quantitative (minimum inhibitory concentration, MIC) methods in 200 strains of Escherichia coli which had been
isolated between 1999 and 2018 from clinical cases of diarrhoea in neonatal and post-weaned piglets. Results
showed resistance around 100% for amoxicillin and tetracycline since 1999, and a progressive increase in ceftiofur
resistance throughout the studied period. For colistin, it was detected a resistance peak (17.5% of the strains) in the
2011–2014 period. Concerning gentamicin, 11 of 30 strains with intermediate susceptibility by the disk diffusion
method were resistant by MIC. Besides, the most frequent antimicrobial resistance genes were the extended-
spectrum beta-lactamase (ESBL) blaCTX-M (13.5% of strains, being CTX-M-14, CTX-M-1 and CTX-M-32 the most
prevalent genomes, followed by CTX-M-27, CTX-M-9 and CTX-M-3), AmpC-type beta-lactamase (AmpC) blaCMY-2
(3%) and colistin resistance genes mcr-4 (13%), mcr-1 (7%) and in less proportion mcr-5 (3%). Interestingly, these
mcr genes were already detected in strains isolated in 2000, more than a decade before their first description.
However, poor concordance between the genotypic mcr profile and the phenotypical testing by MIC was found in
this study. These results indicate that although being a current concern, resistance genes and therefore
antimicrobial resistant phenotypes were already present in pig farms at the beginning of the century.
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Background
Levy et al. (1976) observed the direct link between the
usage of antibiotics in livestock and the apparition of
resistances in human pathogens by plasmid transfer [1].
Nowadays, antibiotics are still extensively used in the
animal husbandry sector, especially in those farming
activities with the most intensive systems such as pork
production. Pig industry is the most important livestock
sector in Spain. Recent studies show that the percentage
of resistance to last-resort drugs such as colistin is con-
siderably higher than in other European regions [2, 3].
Following these reports and considering the worldwide
increasing prevalence of antimicrobial resistance (AMR)
in food-producing animals, the aim of this study was to
determine the present situation of AMR in pig farms from
Spain and its evolution since 1999, as well as the prevalence
of the most common resistance genes (colistin resistance
plasmids (mcr), genes encoding for extended-spectrum beta-
lactamases (ESBL), AmpC-type beta-lactamases (AmpC) and
carbapenemases).
Methods
One hundred and sixty pathogenic E. coli strains isolated
from swine enteric clinical cases were randomly recovered
from the strain collection of the Infectious Diseases
Laboratory of the Veterinary Faculty of Barcelona (Spain)
between 1999 and 2014 (8–16 strains per year). Those
cases came from farms of different counties of Spain with
neonatal or post-weaning diarrhoea problems. In addition,
forty different E. coli strains isolated throughout 2017 and
2018 were collected from ten farms in Catalonia (NE of
Spain). The primary objective was to determine the evolu-
tion of antimicrobial resistances in E. coli strains since
1999 against the most commonly used antibiotics in
swine. A second objective was to study the presence of
resistance genes (ESBL, carbapenemase and mcr) by
molecular methods in all the selected strains.
For this purpose, strains from the collection were
recovered in brain heart infusion and then streaked
on blood agar and MacConkey agar, both incubated
aerobically at 37 °C overnight. Faecal samples collected in
2017 and 2018 were plated in the same culture media and
conditions in order to isolate E. coli strains. The qualitative
disk diffusion method on Mueller Hinton agar was used to
test susceptibility to amoxicillin, tetracycline, gentamicin,
enrofloxacin, ceftiofur and colistin according to the Clinical
and Laboratory Standards Institute (CLSI) [3, 4] using the
antibiotic disks and breakpoints shown in Table 1.
Amoxicillin-clavulanic resistance was tested in strains re-
sistant to ceftiofur to predict the production of AmpC
beta-lactamase. At the same time, the minimum inhibitory
concentration (MIC) of colistin was determined for all
strains by broth microdilution method in 96-wells micro-
plates, using a dilution prepared from colistin sulphate of
21958 IU/mg (731,93 μg/mg) potency [4]. Additionally, for
strains with resistant, intermediate and sensitive but close
to the breakpoint results to gentamicin, MIC values were
also determined by broth microdilution with a dilution
from gentamicin sulphate. Both MIC microdilution proce-
dures were manually prepared and performed according to
CLSI standards, using the reference strain E. coli ATCC
25922 as control in each plate. CLSI breakpoints shown in
Table 2 were used.
The most common genes coding for ESBL (blaCTX-M,
blaTEM, blaSHV), AmpCs (blaCMY-1, blaCMY-2), carbape-
nemases (blaOXA) and colistin resistance (mcr-1, mcr-2,
mcr-3, mcr-4 and mcr-5) genes were analysed by PCR in
all strains as previously described [8]. Controls for all
genes were provided by Dr. Migura (IRTA-CReSA,
Bellaterra, Spain). Amplified PCR products were Sanger
sequenced for verification at the Genomic and Bioinfor-
matics Service of the Universitat Autònoma de Barcelona
(Bellaterra, Spain). Sequences were analysed by using
BioEdit software and blasted against the public database
(National Center for Biotechnology Information, NCBI).
Statistics were applied for determining antimicrobial
resistance differences among the periods studied using
the Chi-Square Test (Fisher Exact P-values) and graphed
using the program Excel. Antimicrobials with statistical
differences were further analysed by T-Square. Finally,
Table 1 Concentrations and breakpoints of the antibiotic disks used for the disk diffusion method
Antibiotica Concentration
(μg/mg)
Breakpoint (mm) Referenceb
S R
Amoxicillin 25 ≥ 17 ≤ 13 CLSI M100; human [5]
Amoxicillin - clavulanic 30 ≥ 18 ≤ 13 CLSI M100; human [5]
Ceftiofur 30 ≥ 21 ≤ 17 CLSI VET08; cattle E. coli and
swine Salmonella cholerasuis [6]
Colistin 50 ≥ 15 < 15 CA-SFM; veterinary [7]
Enrofloxacin 5 ≥ 23 ≤ 16 CLSI VET08; dog, cat and poultry [6]
Gentamicin 10 ≥ 16 ≤ 12 CLSI VET08; dog, horse [6]
Tetracycline 30 ≥ 15 ≤ 11 CLSI M100; human [5]
aAntibiotic disks: BBL™ brand. bCLSI veterinary breakpoints were preferably used. If not available, CLSI human or CA-SFM veterinary breakpoints were used
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associations between mcr genes and MIC values were
assessed by Odds-ratio tests.
Results
The disk diffusion tests demonstrated that 110 of 200
strains (55%) were multidrug-resistant (MDR), namely
resistant to three or more antibiotics. Because of the low
number of samples per year, strains were grouped in 4-
year periods from 1999 to 2014 (P1 = 1999, 2000, 2001
and 2002, P2 = 2003, 2004, 2005 and 2006, P3 = 2007,
2008, 2009 and 2010, P4 = 2011, 2012, 2013 and 2014)
with 40 strains per period, and a last group of strains
from 2017 and 2018 (P5), of 40 samples. As shown in
Fig. 1, no significant changes in the MDR percentages
were observed over time (P > 0.05). However, the
percentage of MDR was significantly higher in P5 (65%)
than in P1 and P2 (47.5%) (P < 0.02).
Amoxicillin resistance was observed in 98.5% (197/
200) of the strains. There were no significant differences
in amoxicillin resistance among studied periods (P >
0.05), as can be seen in Fig. 2. Similarly, 94.5% (189/200)
strains were resistant to tetracycline, with no significant
changes between 1999 and 2018 (P > 0.05). Resistance to
ceftiofur was detected in 15.5% of the samples (31/200).
As can be observed in Fig. 2, resistance to this antibiotic
was significantly higher in P5 than in the earlier periods
(P < 0.02). Enrofloxacin showed a level of resistance of
42.5% (85/200), a percentage that has remained practic-
ally stable in these past twenty years (P > 0.05). Gentami-
cin resistance was detected in 25.5% (51/200) strains,
with no significant differences (P > 0.05) over the studied
years. Thirty strains (15%) presented intermediate
susceptibility to gentamicin. Among these, 36.67% (11/
30) had a resistant MIC when tested by microdilution.
Of the eight strains with a sensitive result to gentamicin
by disk diffusion but close to the breakpoint (16 mm),
five presented resistant MIC values. The qualitative
results of resistance to colistin did not show significant
changes throughout the period (P > 0.05), with only 4.67%
of resistant strains. In contrast, the MIC procedure dem-
onstrated significant differences among the studied years
(P < 0.02). Whereas there was no colistin resistance in
neither of the three first periods, an increase was observed
in P4 (P < 0.05), with 17.5% (7/40) of strains resistant to
colistin. However, the percentage in 2017 and 2018
declined significantly (P < 0.02) to 7.5% (3/40) (Fig. 2).
The frequencies of the AMR genes are shown in
Table 3. Only the ESBL gene blaCTX-M, was detected, in
13.5% (27/200) strains, which showed a slight a tendency
to increase throughout the studied period (P < 0.05). Out
of the 27 strains, the sequences of 18 strains could be
obtained (Table 3). The most prevalent was blaCTX-M-14,
with 33.33% (6/18), followed by blaCTX-M-1 with 27.78%,
blaCTX-M-32 with 16.67% (3/18) and blaCTX-M-3 and
blaCTX-M-9 both in 5.56% (1/18) of the strains. No
significant trend patterns were described for any of the
other AMR genes. blaCMY-2 was detected in 3% (6/200)
of strains. The mcr-4 was the most frequent colistin re-
sistance gene, in 13% (26/200) strains. Both mcr-1 and
mcr-5 were detected in 7% (14/200) and 3% (6/200)
strains respectively. Out of the 43 strains positive to at
least one mcr gene, forty (93.02%) had a sensitive MIC
value (0.5–2 μg/mL), and seven (4.46%) of the 157
strains negative to mcr genes presented a resistant MIC.
Therefore, no significant association was found between
mcr-positivity and MIC results (P > 0.05). The MIC dis-
tribution by mcr PCR results can be observed in Table 4.
blaTEM, blaSHV, blaCMY-1, blaOXA, mcr-2 and mcr-3
genes were not detected in any of the studied strains.
Discussion
In this study, MDR E. coli strains were found in a high
proportion of porcine diarrheic cases from Spanish
farms since 1999. In addition, an increase of these MDR
frequencies was observed in 2017 and 2018, being
amoxicillin and tetracycline the antimicrobials with the
highest levels of resistance (98.5 and 94.5% respectively).
Similar resistance levels to these antibiotics have been
previously described in enterobacteria from pig farms of
Catalonia in 2002 [9, 10]. According to the EMA [11],
tetracycline was the most sold antibiotic family for
Table 2 Potency and breakpoints used for the microdilution
methods for colistin and gentamicin
Antibiotica Potency
(μg/mg)
Breakpoint (μg/mL) Referenceb
S R
Colistin 731.93 ≤ 2 > 2 CLSI M100; human [5]
Gentamicin 614 ≤ 2 ≥ 8 CLSI VET08; dog, horse [6]
aAntibiotic powder: Sigma®. bCLSI veterinary breakpoints were preferably used.
If not available, CLSI human breakpoints were used
Fig. 1 Minimum, maximum and mean percentage of MDR during
the studied years, grouped in five periods (P1 = 1999–2002, P2 =
2003–2006, P3 = 2007–2010, P4 = 2011–2014, P5 = 2017 and 2018)
according to the results obtained by disk diffusion with the
exception of colistin, for which the results of the MIC were
considered. Strains with intermediate susceptibility to gentamicin by
disk diffusion but resistant MIC were considered resistant. The line
represents the interval of values in the defined period from the
minimum to the maximum percentage, and the mean (number of
MDR strains in the period divided by the total of strains of the
period) is represented by the triangle
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Fig. 2 Percentages of resistance to each of the 6 antibiotics in the five defined periods (P1 = 1999–2002, P2 = 2003–2006, P3 = 2007–2010, P4 =
2011–2014, P5 = 2017 and 2018) according to the results obtained by disk diffusion with the exception of colistin, for which the results of the
MIC were considered. Strains with intermediate susceptibility to gentamicin by disk diffusion but resistant MIC were considered resistant
Table 3 Number of E. coli isolates positive to the different AMR genes and blaCTX-M genotype sequencing results by year of isolation
Year (strains per year) mcr-1 mcr-4 mcr-5 blaCMY-2 blaCTX-M blaCTX-M genotype
2000 (10) 2
2001 (11) 2 3 2 1
2002 (9) 1 1 2
2003 (10) 5 1
2004 (9) 3 1
2005 (11) 3 2 2 CTX-M-14 (1)
CTX-M-32 (1)
2006 (10) 1
2007 (10) 2 CTX-M-14 (1)
2008 (10) 2 3
2009 (8) 1 1 2 CTX-M-1 (1)
CTX-M-14 (1)
2010 (12) 1 4 CTX-M-9 (1)
CTX-M-32 (1)
2011 (16) 2 2 1 2 CTX-M-1 (2)
2012 (13) 2 2
2013 (6) 1
2014 (5) 3
2017 (34) 3 1 9 CTX-M-1 (2)
CTX-M-14 (3)
CTX-M-32 (1)
CTX-M-3 (1)
CTX-M-27 (2)
2018 (6) 1 2
Total (%) 14 (7) 26 (13) 6 (3) 6 (3) 27 (13.5)
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animal production in Spain from 2010 to 2015 and is
still highly used in pigs and other species. Similarly,
penicillins proved to be the second most consumed anti-
biotic family in the same report, which would explain
the high levels of resistance to amoxicillin in the studied
strains.
By contrast, resistance to ceftiofur was considerably
lower (15.5%), as third and fourth generation cephalo-
sporins are less used in livestock [11]. However, the
ESBL increase described during the last decades [12]
would account for the significant difference (P < 0.02) in
ceftiofur resistance between P5 and the earlier periods.
On the other hand, enrofloxacin presented a level of re-
sistance around 40% that has remained practically stable
in these past twenty years. Although this fluoroquinolone
is exclusively for veterinary use, previous studies have
demonstrated that enrofloxacin treatments in pigs in-
creases Campylobacter coli resistance to other fluoroqui-
nolones such as ciprofloxacin [13], broadly used in
humans. Out of the 28 strains resistant to ceftiofur, 16
(56.14%) presented resistance to amoxicillin-clavulanic,
which has been described as an indicator of the presence
of AmpC, although not highly specific [14].
Resistance to gentamicin in swine E. coli has been less
reported than to other aminoglycosides like strepto-
mycin [9, 15]. In this study, gentamicin resistance was
detected in 25.5% (51/200) strains, with no significant
differences (P > 0.05) over the studied years. The low but
considerable percentage of intermediate strains (15%)
and the fact that 36.67% (11/30) of these presented a
resistant MIC suggests that disk diffusion results for
testing gentamicin susceptibility should be interpreted
with caution.
Colistin results from the qualitative MIC method were
considered for the analysis, as the disk diffusion method
has been described as not reliable when testing poly-
myxins susceptibility [5], and the results in the present
study reinforce this fact. From 2013 to 2015, Spain was
the European country with the highest sales of poly-
myxins for food-producing animals [11], which might
explain the significant increase in colistin resistance in
P4. The following significant decrease in colistin resist-
ance in P5 might be related to the 97% reduction in the
use of colistin in swine from 2015 to 2018 in Spain re-
ported by the AEMPS [16].
In accordance with previous studies in humans and
pigs [17], blaCTX-M was the most frequent ESBL gene
in our study, with upward trend throughout the years.
On the other hand, blaCMY-2 and the six blaCTX-M
genotypes detected in this study (CTX-M-1, CTX-M-3,
CTX-M-9, CTX-M-14, CTX-M-27 and CTX-M-32) had
been already been reported in E. coli isolates from
pigs [12, 18].
Since their first report by Liu et al. [19], mcr genes in
E. coli strains have been worldwide described in both
humans and livestock. It has been speculated that colis-
tin use in animal production could be the original source
of these genes [20]. Although mcr-4 was firstly described
in 2017 by Carattoli et al. [21], in the present study mcr-
4 (13%,) was already detected in E. coli strains isolated in
2001. Also, mcr-1 (7%,) was the second most prevalent
colistin resistance gene, with the first positive strains
detected in 2005. Finally, mcr-5, which was firstly de-
scribed in 2017 by Borowiak et al. [22], was identified in
four strains from 2001 and 2002, but it was not detected
afterwards. The existence of strains positive to a mcr
gene but with a sensitive MIC value suggests that,
although they do not express it, strains with a “sensitive”
phenotype could contain a mcr gene and might end up
expressing it. Conversely, the seven strains found pheno-
typically resistant to colistin and negative for the mcr
genes analysed, might suggest the presence of other mcr
genes such as mcr-6 and mcr-8, originally described in
pigs [23, 24] or other genes such as pmrA that can con-
fer intrinsic resistance to colistin in E. coli [25] and have
not been included in the study. Besides, colistin resist-
ance could occur via chromosomal mutations, although
this mechanism is often unstable [19].
Conclusions
E. coli strains containing blaCTX-M and mcr-4 and mcr-1
genes have been the most frequently detected in pig farms,
since at least 20 years ago in the case of mcr-4. However,
the poor concordance between the genotypic mcr profile
and the MIC phenotypical testing observed in this study
deserves further investigation. Finally, it is concerning the
high levels of AMR for tetracycline and amoxicillin and
the increase of cephalosporin and colistin resistance
during these two decades. Thus, antimicrobial surveillance
should be maintained, and research strengthened in new
approaches to control of bacterial infections in pigs by
reducing antibiotic consumption.
Abbreviations
AMR: Antimicrobial resistance; ESBL: Extended-spectrum beta-lactamases;
MDR: Multidrug-resistant; MIC: Minimal inhibitory concentration
Table 4 Number of strains by MIC colistin values and mcr PCR
results
Colistin MIC (μg/mL) mcr-1 mcr-4 mcr-5 mcr absencea
Resistant > 8 1 2 0 4
4 0 0 0 3
Sensitive 2 2 2 0 44
< 2 11 20 6 83
amcr-1, mcr-2, mcr-3 mcr-4 and mcr-5 were tested
Aguirre et al. Porcine Health Management             (2020) 6:8 Page 5 of 6
Authors’ contributions
LA and MM initiated and planned the work. LA, AV and CS selected the
samples, performed experiments and analysed data. MT and NR assisted for
experiments, media preparation and laboratory equipment. MM and LD
supervised the work. LA, MM and LD discussed the results and drafted the
manuscript. All co-authors revised the manuscript and approved the final
submitted version.
Funding
LA was supported by a Collaboration scholarship from the Ministerio de
Educación, Cultura y Deporte from the Spanish Government. AV was
supported by a PIF fellowship from the Universitat Autònoma de Barcelona.
The funders had no role in the study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Availability of data and materials
The datasets generated during the current study are available from the
corresponding author on reasonable request.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Departament de Sanitat i d’Anatomia Animals, Universitat Autònoma de
Barcelona, Edifici V, Travessera dels Turons, 08193 Bellaterra, Spain. 2UAB,
Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la
Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Received: 14 October 2019 Accepted: 10 February 2020
References
1. Levy SB, Fitzgerald GB, Macone AB. Spread of antibiotic-resistant plasmids
from chicken to chicken and from chicken to man. Nature. 1976;260:40–2.
2. García V, García-Meniño I, Mora A, Flament-Simon SC, Díaz-Jiménez D,
Blanco JEJ, et al. Co-occurrence of mcr-1, mcr-4 and mcr-5 genes in
multidrug-resistant ST10 Enterotoxigenic and Shiga toxin-producing
Escherichia coli in Spain (2006-2017). Int J Antimicrob Agents. 2018;52:104–8.
3. Rhouma M, Beaudry F, Letellier A. Resistance to colistin: what is the fate for
this antibiotic in pig production? Int J Antimicrob Agents. 2016;48:119–26.
4. EMEA. Committee for Veterinary Medicinal Products. Colistin: Summary
Report Colistin (2); 2002. EMEA/MRL/815/02-FINAL
5. CLSI. Performance standards for antimicrobial susceptibility testing. 29th
edition. CLSI supplement M100. Wayne: Clinical and Laboratory Standards
Institute; 2019.
6. CLSI, editor. Performance standards for antimicrobial disk and dilution
susceptibility tests for Bacteria isolated from animals. 4th ed. CLSI
supplement VET08. Wayne: Clinical and Laboratory Standards Institute; 2018.
7. Comité de l’Antibiogramme (CA-SFM). Recommandations Vétérinaires 2018.
Societé Française de Microbiologie 2018.
8. Darwich L, Vidal A, Seminati C, Albamonte A, Casado A, López F, et al. High
prevalence and diversity of extended-spectrum β-lactamase and emergence
of OXA-48 producing Enterobacterales in wildlife in Catalonia. PLoS One.
2019;14:e0210686.
9. Mateu EM, Martin M, Darwich L, Mejía W, Fría N, García Peña FJ.
Antimicrobial susceptibility of Salmonella strains isolated from swine in
Catalonia, Spain. Vet Rec. 2002;150:147–50.
10. Cameron-Veas K, Fraile L, Napp S, Garrido V, Grilló MJ, Migura-Garcia L.
Multidrug resistant Salmonella enterica isolated from conventional pig farms
using antimicrobial agents in preventative medicine programmes. Vet J
Elsevier Ltd. 2018;234:36–42.
11. European Medicines Agency, European Surveillance of Veterinary
Antimicrobial Consumption. Sales of veterinary antimicrobial agents in 30
European countries in 2015. 2017; EMA/184855/2017.
12. Carattoli A. Animal reservoirs for extended spectrum β-lactamase producers.
Clin Microbiol Infect European Soc Clin Microbiol Infect Dis. 2008;14:117–23.
13. Delsol AA, Sunderland J, Woodward MJ, Pumbwe L, Piddock LJV, Roe JM.
Emergence of fluoroquinolone resistance in the native Campylobacter coli
population of pigs exposed to enrofloxacin. J Antimicrob Chemother.
2004;53:872–4.
14. Tenover FC, Emery SL, Spiegel CA, Bradford PA, Eells S, Endimiani A, et al.
Identification of plasmid-mediated AmpC β-lactamases in Escherichia coli,
Klebsiella spp., and Proteus species can potentially improve reporting of
cephalosporin susceptibility testing results. J Clin Microbiol. 2009;47:294–9.
15. Gibbons JF, Boland F, Egan J, Fanning S, Markey BK, Leonard FC.
Antimicrobial resistance of Faecal Escherichia coli isolates from pig farms
with different durations of in-feed antimicrobial use. Zoonoses Public
Health. 2016;63:241–50.
16. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). España
reduce un 7,2% el consumo de antibióticos en salud humana y un 32,4%
las ventas de antibióticos veterinarios. In: Notas informativas de la AEMPS;
2019. https://www.aemps.gob.es/informa/notasInformativas/laAEMPS/2019/
NI-AEMPS-12-2019-consumo-total-antibioticos.htm. Accessed 2 Oct 2019.
17. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum β-
lactamase-producing and AmpC-producing Escherichia coli from livestock
and companion animals, and their putative impact on public health: a
global perspective. Clin Microbiol Infect. 2012;18:646–55.
18. Zheng H, Zeng Z, Chen S, Liu Y, Yao Q, Deng Y, et al. Prevalence and
characterisation of CTX-M β-lactamases amongst Escherichia coli isolates
from healthy food animals in China. Int J Antimicrob Agents. Elsevier B V.
2012;39:305–10.
19. Liu Y, Wang Y, Walsh TR, Yi L, Zhang R, Spencer J, et al. Emergence of
plasmid-mediated colistin resistance mechanism MCR-1 in animals and
human beings in China: a microbiological and molecular biological study.
Lancet Infect Dis. 2016;16:161–8.
20. Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity,
susceptibility testing, and resistance mechanisms encoded by plasmids or
chromosomes. Clin Microbiol Rev. 2017;30:557–96.
21. Carattoli A, Villa L, Feudi C, Curcio L, Orsini S, Luppi A, et al. Novel plasmid-
mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli,
Italy 2013, Spain and Belgium, 2015 to 2016. Euro Surveill. 2017;22:1–5.
22. Borowiak M, Fischer J, Hammerl JA, Hendriksen RS, Szabo I, Malorny B.
Identification of a novel transposon-associated phosphoethanolamine
transferase gene, mcr-5, conferring colistin resistance in d-tartrate
fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J
Antimicrob Chemother. 2017;72:3317–24.
23. AbuOun M, Stubberfield EJ, Duggett NA, Kirchner M, Dormer L, Nunez-
Garcia J, et al. mcr-1 and mcr-2 variant genes identified in Moraxella species
isolated from pigs in Great Britain from 2014 to 2015. J Antimicrob
Chemother. 2017;72:2745–9.
24. Wang X, Wang Y, Zhou Y, Li J, Yin W, Wang S, et al. Emergence of a novel
mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella
pneumoniae article. Emerg Microbes Infect Springer US. 2018;7:1–9.
25. Aghapour Z, Gholizadeh P, Ganbarov K, Bialvaei AZ, Mahmood SS,
Tanomand A, et al. Molecular mechanisms related to colistin resistance in
enterobacteriaceae. Infect Drug Resist. 2019;12:965–75.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Aguirre et al. Porcine Health Management             (2020) 6:8 Page 6 of 6
